Stereotactic body radiation therapy (SBRT), defined as the delivery of >5Gy per fraction, has emerged as a well-established standard of care option for the definitive management of localized prostate ...
At a median follow-up of 19.6 months, the median PSA was 0.028 ng/mL. 18/100 patients developed biochemical recurrence, with a median time to recurrence of 10 months. The biochemical recurrence-free ...
A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback